Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Benralizumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Fasenra

    02 5Of which, Benralizumab royalty

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Fasenra

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Fasenra

    United Kingdom
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    AstraZeneca

    Benralizumab

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 949

    2019 Revenue in Millions : 704

    Growth (%) : 35

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Of which, Benralizumab royalty

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Of which, Benralizumab royalty

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Kyowa Kirin

    Benralizumab

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 20

    2019 Revenue in Millions : 84

    Growth (%) : -76

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Fasenra

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Fasenra

    United Kingdom
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    AstraZeneca

    Benralizumab

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 1,258

    2020 Revenue in Millions : 949

    Growth (%) : 33

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Of which, Benralizumab royalty

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Of which, Benralizumab royalty

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Kyowa Kirin

    Benralizumab

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 142

    2020 Revenue in Millions : 104

    Growth (%) : 53

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Fasenra

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Fasenra

    United Kingdom
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    AstraZeneca

    Benralizumab

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 1,396

    2021 Revenue in Millions : 1,258

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Of which, Benralizumab royalty

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Of which, Benralizumab royalty

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Kyowa Kirin

    Benralizumab

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 163

    2021 Revenue in Millions : 142

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Fasenra

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Fasenra

    United Kingdom
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    AstraZeneca

    Benralizumab

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2023 Revenue in Millions : 1,553

    2022 Revenue in Millions : 1,396

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Of which, Benralizumab royalty

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Of which, Benralizumab royalty

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Kyowa Kirin

    Benralizumab

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2023 Revenue in Millions : 185

    2022 Revenue in Millions : 163

    Growth (%) : 27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Fasenra

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Fasenra

    United Kingdom
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    AstraZeneca

    Benralizumab

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2018 Revenue in Millions : 297

    2017 Revenue in Millions : 1

    Growth (%) : 29600%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Fasenra

    Benralizumab

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Fasenra

    United Kingdom
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    AstraZeneca

    Benralizumab

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2019 Revenue in Millions : 704

    2018 Revenue in Millions : 297

    Growth (%) : 137

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF